These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 193152)

  • 1. The role of the blood in metabolism of prostaglandin E1 in the cat lung.
    Cozzini BO; Dawson CA
    Prostaglandins; 1977 Apr; 13(4):587-97. PubMed ID: 193152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further identification of PGE1 metabolites formed in the cat lung.
    Cozzini BO; Dawson CA
    Can J Physiol Pharmacol; 1977 Apr; 55(2):311-3. PubMed ID: 871963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E1 uptake by isolated cat lungs perfused with physiological salt solution.
    Linehan JH; Dawson CA; Wagner-Weber VM
    J Appl Physiol Respir Environ Exerc Physiol; 1981 Feb; 50(2):428-34. PubMed ID: 7204214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin removal and metabolism by isolated perfused rat lung.
    Anderson MW; Eling TE
    Prostaglandins; 1976 Apr; 11(4):645-77. PubMed ID: 959568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of [2-14C]prostaglandin E1 on passage through the pulmonary circulation.
    Dawson CA; Cozzini BO; Lonigro AJ
    Can J Physiol Pharmacol; 1975 Aug; 53(4):610-5. PubMed ID: 1100206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasodilator actions of prostaglandin 6-keto-E1 in the pulmonary vascular bed.
    Hyman AL; Kadowitz PJ
    J Pharmacol Exp Ther; 1980 Jun; 213(3):468-72. PubMed ID: 7193724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo disposition of prostaglandin E1 via pharmacokinetic characterization of its pulmonary metabolite.
    Verburg M; Bothwell W; Daniels EG; Fitzpatrick FA
    J Cardiovasc Pharmacol; 1982; 4(6):980-5. PubMed ID: 6185792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination from the circulation of cats of 6-keto-prostaglandin E1 compared with prostaglandins E2 and I2.
    Förstermann U; Neufang B
    J Pharm Pharmacol; 1983 Nov; 35(11):724-8. PubMed ID: 6139453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymatic inactivation of 6-keto-prostaglandin E1 in vitro: comparison with prostaglandin E1.
    Berry CN; Hoult JR; Griffiths RJ; Moore PK
    Biochem Pharmacol; 1984 Apr; 33(8):1277-84. PubMed ID: 6549614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-hydroxylation of prostaglandin E1 in the isolated perfused lungs of pregnant rabbits.
    Leithauser MT; Roerig DL; Winquist SM; Gee A; Okita RT; Masters BS
    Prostaglandins; 1988 Dec; 36(6):819-33. PubMed ID: 3244833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of prostaglandin E1 metabolites on the induction of arterial thromboresistance.
    Sinzinger H; Neumann I; O'Grady J; Rogatti W; Peskar BA
    Prostaglandins Other Lipid Mediat; 1998 Apr; 55(5-6):265-75. PubMed ID: 9653766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake and metabolism of prostaglandin E1 in isolated perfused fetal, newborn and adult rabbit lungs.
    Olson EB; Ghias-Ud-Din M; Rankin J
    Prostaglandins Leukot Med; 1982 Oct; 9(4):429-36. PubMed ID: 6960371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of plasma protein on the inhibitory effects of indocyanine green and bromcresol green on pulmonary prostaglandin E1 extraction.
    Dawson CA; Linehan JH; Rickaby DA; Roerig DL
    Br J Pharmacol; 1984 Mar; 81(3):449-55. PubMed ID: 6538103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A radioimmunoassay for the unstable pulmonary metabolites of prostaglandin E1 and E2: an indirect index of their in vivo disposition and pharmacokinetics.
    Bothwell W; Verburg M; Wynalda M; Daniels EG; Fitzpatrick FA
    J Pharmacol Exp Ther; 1982 Feb; 220(2):229-35. PubMed ID: 6948952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6-Keto-prostaglandin E1: its formation by platelets from prostacyclin and resistance to pulmonary degradation.
    Berry CN; Hoult JR
    Pharmacology; 1983; 26(6):324-30. PubMed ID: 6348806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the extent to exogenous prostaglandin I2 is converted to 6-keto-prostaglandin E1 in human subjects.
    Jackson EK; Goodman RP; Fitzgerald GA; Oates JA; Branch RA
    J Pharmacol Exp Ther; 1982 Apr; 221(1):183-7. PubMed ID: 7038095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of O2 exposure on pulmonary metabolism of prostaglandin E2.
    Klein LS; Fisher AB; Soltoff S; Coburn RF
    Am Rev Respir Dis; 1978 Sep; 118(3):622-5. PubMed ID: 707883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Separation of prostaglandin metabolites on sephadex LH 20 columns.
    Hansen HS; Bukhave K
    Prostaglandins; 1978 Aug; 16(2):311-8. PubMed ID: 704935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A kinetic model of prostaglandin metabolism in the lung.
    Linehan JH; Dawson CA
    J Appl Physiol Respir Environ Exerc Physiol; 1979 Aug; 47(2):404-11. PubMed ID: 381264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of 6-keto prostaglandin E1 in mammalian kidneys.
    Griffiths RJ; Moore PK
    Br J Pharmacol; 1983 May; 79(1):149-55. PubMed ID: 6347300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.